Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-01-05 @ 2:52 PM
Study NCT ID:
NCT03704467
Status:
COMPLETED
Last Update Posted:
2020-11-13
First Post:
2018-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-03
First Submit QC Date:
None
Study First Post Date:
2018-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-10-21
Results First Submit QC Date:
None
Results First Post Date:
2020-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-21
Last Update Post Date:
2020-11-13
Last Update Post Date Type:
ACTUAL